135 related articles for article (PubMed ID: 34275800)
1. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
[TBL] [Abstract][Full Text] [Related]
2.
Fareed MM; El-Esawi MA; El-Ballat EM; Batiha GE; Rauf A; El-Demerdash FM; Alhumaydhi FA; Alsagaby SA
Biomed Res Int; 2021; 2021():5515692. PubMed ID: 34195264
[TBL] [Abstract][Full Text] [Related]
3. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
[TBL] [Abstract][Full Text] [Related]
5. The Design and Synthesis of
Wang P; Jiang L; Cao Y; Ye D; Zhou L
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890679
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
[TBL] [Abstract][Full Text] [Related]
7. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
8. Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches.
Yousaf N; Alharthy RD; Maryam ; Kamal I; Saleem M; Muddassar M
PeerJ; 2023; 11():e14936. PubMed ID: 37051414
[TBL] [Abstract][Full Text] [Related]
9. Targeting PGAM1 in cancer: An emerging therapeutic opportunity.
Yang GJ; Tao F; Zhong HJ; Yang C; Chen J
Eur J Med Chem; 2022 Dec; 244():114798. PubMed ID: 36215859
[TBL] [Abstract][Full Text] [Related]
10. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.
Huang K; Liang Q; Zhou Y; Jiang LL; Gu WM; Luo MY; Tang YB; Wang Y; Lu W; Huang M; Zhang SZ; Zhuang GL; Dai Q; Shen QC; Zhang J; Lei HM; Zhu L; Ye DY; Chen HZ; Zhou L; Shen Y
Cell Metab; 2019 Dec; 30(6):1107-1119.e8. PubMed ID: 31607564
[TBL] [Abstract][Full Text] [Related]
11. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
[TBL] [Abstract][Full Text] [Related]
13. Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.
Li N; Liu X
Onco Targets Ther; 2020; 13():1787-1795. PubMed ID: 32161473
[TBL] [Abstract][Full Text] [Related]
14. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.
Wen CL; Huang K; Jiang LL; Lu XX; Dai YT; Shi MM; Tang XM; Wang QB; Zhang XD; Wang PH; Li HT; Ruan XX; Wang LW; Wang XJ; Wang Q; Lu W; Xiang XQ; Sun X; Xu YH; Lai LH; Zhan Q; Li HW; Peng CH; Chen J; Huang JY; Ye DY; Chen SJ; Chen Z; Li M; Fang Y; Shen BY; Zhou L
Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23264-23273. PubMed ID: 31662475
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
16. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
Nat Commun; 2013; 4():1790. PubMed ID: 23653202
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
[TBL] [Abstract][Full Text] [Related]
18. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
[TBL] [Abstract][Full Text] [Related]
19. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
[TBL] [Abstract][Full Text] [Related]
20. Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors.
Huang K; Jiang L; Li H; Ye D; Zhou L
Molecules; 2019 Feb; 24(5):. PubMed ID: 30818883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
